NCT02458274View on ClinicalTrials.gov

Microparticles and Bronchiolitis Obliterans Syndrome

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2020

Study Completion Date

July 31, 2020

Conditions
Bronchiolitis Obliterans
Interventions
OTHER

Dosage of Microparticles (MPs) in broncho-alveolar lavage fluid (BALF)

Trial Locations (1)

+67000

CHU Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT02458274 - Microparticles and Bronchiolitis Obliterans Syndrome | Biotech Hunter | Biotech Hunter